[Pharmacological profile and clinical findings of a new phosphate binder, ferric citrate hydrate (Riona® Tablets)].

Subjects

Subjects :

Animals
Chelating Agents adverse effects
Clinical Trials as Topic
Ferric Compounds adverse effects
Ferritins blood
Gastrointestinal Diseases chemically induced
Humans
Hyperphosphatemia etiology
Peritoneal Dialysis
Renal Dialysis
Renal Insufficiency, Chronic complications
Tablets
Chelating Agents pharmacology
Chelating Agents therapeutic use
Ferric Compounds pharmacology
Ferric Compounds therapeutic use
Hyperphosphatemia drug therapy

Details

Language :

Japanese

ISSN :

0015-5691

Volume :

144

Issue :

6

Database :

MEDLINE

Journal :

Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Publication Type :

Academic Journal

Accession number :

25492366

Full Text :

https://doi.org/10.1254/fpj.144.294